Cover image for Vol. 10 Issue 7

Editor-in-Chief: Natalia Ortúzar

Impact Factor: 2.968

ISI Journal Citation Reports © Ranking: 2014: 19/59 (Chemistry Medicinal); 83/254 (Pharmacology & Pharmacy)

Online ISSN: 1860-7187

Associated Title(s): Angewandte Chemie International Edition, Chemistry - A European Journal, Chemistry – An Asian Journal, ChemBioChem, Medicinal Research Reviews, Molecular Informatics

Recently Published Issues

See all

Latest News

Browse more news


Follow ChemMedChem on Twitter

June 26, 2015

Editor's Picks: Issue 07/2015

Editor's Picks: Issue 07/2015Editor's picks for issue 07: In this issue, a Minireview by Matteo Masetti et al. and a Full Paper by Stefan Günther, Irmgard Merfort, and colleagues illustrate how the latest advances in computational chemistry are solving problems in drug design and discovery. Read more...

Remember, these articles are free to access throughout July! Be sure to sign up for e-mail alerts or follow us on Facebook or Twitter to stay updated with the latest news.

Your Comment...

[Browse more news]

Recently Published Articles

  1. Active Site Mapping of Human Cathepsin F with Dipeptide Nitrile Inhibitors

    Janina Schmitz, Norbert Furtmann, Moritz Ponert, Dr. Maxim Frizler, Dr. Reik Löser, Prof. Dr. Ulrike Bartz, Prof. Dr. Jürgen Bajorath and Prof. Dr. Michael Gütschow

    Article first published online: 26 JUN 2015 | DOI: 10.1002/cmdc.201500151

    Thumbnail image of graphical abstract

    Mapping with nitriles: For human cathepsin F, low-molecular-weight inhibitors have not been developed so far. Therefore, a library of 52 dipeptide nitriles, known to interact in a covalent but reversible manner with the active site cysteine, was evaluated for cathepsin F inhibition. With the kinetic data in hand, optimized candidates were designed, synthesized, and tested to improve the activity profile as cathepsin F inhibitors.

  2. nido-Dicarbaborate Induces Potent and Selective Inhibition of Cyclooxygenase-2

    Dr. Wilma Neumann, Dr. Shu Xu, Dr. Menyhárt B. Sárosi, Dr. Matthias S. Scholz, Brenda C. Crews, Kebreab Ghebreselasie, Dr. Surajit Banerjee, Prof. Dr. Lawrence J. Marnett and Prof. Dr. Dr.  h.c. Evamarie Hey-Hawkins

    Article first published online: 18 JUN 2015 | DOI: 10.1002/cmdc.201500199

    Thumbnail image of graphical abstract

    Potency boost: Replacement of a phenyl moiety in indomethacin with a nido-dicarbaborate group results in a compound with a novel binding mode and markedly increased inhibitory activity and selectivity for COX-2, with a concomitant increase in stability and water solubility, while maintaining strong hydrophobic interactions in the binding site of the enzyme. This shows nido-dicarbaborate to be a promising pharmacophore for a variety of inhibitors.

  3. Synthesis, Characterization, and Antileukemic Properties of Naphthoquinone Derivatives of Lawsone

    Ryuta Inagaki, Masayuki Ninomiya, Prof. Kaori Tanaka and Prof. Mamoru Koketsu

    Article first published online: 18 JUN 2015 | DOI: 10.1002/cmdc.201500189

    Thumbnail image of graphical abstract

    A new angle on leukemia: We present the facile synthesis of naturally occurring derivatives of lawsone. Results from cytotoxicity assays with HL-60 cells indicate that angular-type naphthoquinones act as antiproliferative agents. The particular efficacy of dunnione is brought about by substantial elevations in intracellular GSSG levels. Dunnione analogues have the potential for further development as chemotherapeutic drugs for the treatment of hyperproliferative disorders.

  4. Cinnamamide Derivatives for Central and Peripheral Nervous System Disorders—A Review of Structure–Activity Relationships

    Dr. Agnieszka Gunia-Krzyżak, Katarzyna Pańczyk, Dr. Anna M. Waszkielewicz and Prof. Henryk Marona

    Article first published online: 17 JUN 2015 | DOI: 10.1002/cmdc.201500153

    Thumbnail image of graphical abstract

    Cinnamamide derivatives have been reported to exhibit antiepileptic, antidepressant, neuroprotective, analgesic, anti-inflammatory, muscle relaxant, and sedative/hypnotic properties, and they are known to act on a variety of targets in the central and peripheral nervous systems, including GABAA, NMDA, prostanoid, opioid, histamine H3, TRP cation channels, voltage-gated potassium channels, and HDACs. Here, literature reports on the structure–activity relationships of cinnamamide-derived biologically active agents are reviewed.

  5. You have full text access to this OnlineOpen article
    Freezing the Bioactive Conformation to Boost Potency: The Identification of BAY 85-8501, a Selective and Potent Inhibitor of Human Neutrophil Elastase for Pulmonary Diseases (pages 1163–1173)

    Dr. Franz von Nussbaum, Dr. Volkhart M.-J. Li, Dr. Swen Allerheiligen, Sonja Anlauf, Dr. Lars Bärfacker, Dr. Martin Bechem, Dr. Martina Delbeck, Dr. Mary F. Fitzgerald, Dr. Michael Gerisch, Dr. Heike Gielen-Haertwig, Dr. Helmut Haning, Dagmar Karthaus, Dr. Dieter Lang, Dr. Klemens Lustig, Dr. Daniel Meibom, Prof. Dr. Joachim Mittendorf, Dr. Ulrich Rosentreter, Dr. Martina Schäfer, Prof. Dr. Stefan Schäfer, Dr. Jens Schamberger, Dr. Leila A. Telan and Dr. Adrian Tersteegen

    Article first published online: 17 JUN 2015 | DOI: 10.1002/cmdc.201500131

    Thumbnail image of graphical abstract

    Breathe better: It′s as potent as a low-molecular-weight inhibitor can get! Human neutrophil elastase (HNE) is a driver of pulmonary diseases. We describe the discovery of BAY 85-8501, a small-molecule inhibitor with picomolar in vitro potency against HNE. BAY 85-8501 is currently being assessed in clinical studies for pulmonary diseases.